Slagle Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-33,541
Closed -$3.01M 120
2025
Q1
$3.01M Buy
33,541
+365
+1% +$32.7K 1.34% 26
2024
Q4
$2.65M Buy
33,176
+2,350
+8% +$203K 1.19% 29
2024
Q3
$2.78M Buy
30,826
+2,961
+11% +$249K 1.23% 28
2024
Q2
$2.19M Buy
27,865
+1,761
+7% +$144K 1.12% 35
2024
Q1
$2.28M Sell
26,104
-36,268
-58% -$3.1M 1.23% 32
2023
Q4
$2.58M Buy
62,372
+31,930
+105% +$2.43M 1.48% 20
2023
Q3
$2.39M Buy
30,442
+2,710
+10% +$227K 1.46% 21
2023
Q2
$2.44M Buy
+27,732
New +$2.39M 1.52% 18

Other funds holding MDT

Slagle Financial's MDT Position: Q2 2025 in Review

Slagle Financial sold out of Medtronic (MDT) in Q2 2025, closing a stake of 33,541 shares — an estimated $3.01M sold.

Slagle Financial first reported a position in MDT in Q2 2023 and held it in 8 quarters. The position peaked at $3.01M in Q1 2025. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • Slagle Financial reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • Slagle Financial sold 33,541 Medtronic shares in Q2 2025, an estimated $3.01M.
  • Slagle Financial first reported a position in Medtronic in Q2 2023 and held it in 8 quarters.
  • Slagle Financial's Medtronic position peaked at $3.01M in Q1 2025.
  • 2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Slagle Financial's 13F filing for Q2 2025, filed 11 Aug 2025.